John F. Warner
About John F. Warner
John F. Warner is a Biological Safety Officer at Lawrence Livermore National Laboratory, specializing in liposomal and viral vector delivery systems. He holds a Ph.D. in Microbiology & Immunology and has extensive experience in developing immune- and gene-based technologies for treating infectious diseases and cancer.
Work at Lawrence Livermore National Laboratory
John F. Warner has served as a Biological Safety Officer at Lawrence Livermore National Laboratory since 2011. In this role, he oversees biological safety protocols and ensures compliance with safety regulations. His responsibilities include evaluating biological research projects and managing safety assessments to protect both personnel and the environment. Warner's expertise contributes to the laboratory's mission of advancing scientific research while maintaining high safety standards.
Education and Expertise
Warner holds a Ph.D. in Microbiology & Immunology from The State University of New York at Buffalo. He also earned a Master of Science in Bacteriology and a Bachelor of Science from the University of Idaho. Additionally, he completed post-doctoral studies at the Salk Institute for Biomedical Studies, focusing on Mechanisms of Natural Immunity. His academic background supports his specialization in liposomal and viral vector delivery systems.
Background in Pharmaceutical Research
Warner has extensive experience in the pharmaceutical industry, having worked as Vice President of Research & Development at Valentis from 1998 to 2000 and as Vice President of Gene Therapy & Immunology at Inex Pharmaceuticals from 1995 to 1998. In these roles, he developed novel immune- and gene-based technologies aimed at treating infectious diseases and cancer. His leadership in research and development has shaped significant advancements in these fields.
Achievements in Grant Applications and Regulatory Interactions
Warner has applied for NIH grant applications, demonstrating his commitment to securing funding for innovative research projects. He has a history of positive interactions with regulatory agencies, particularly concerning Investigational New Drug (IND) submissions and the initiation of clinical trials. His understanding of regulatory requirements enhances his ability to navigate complex technology development environments.
Corporate Partnerships and Manufacturing Oversight
Warner has successfully managed scientific aspects of both domestic and international corporate partnerships. His experience includes oversight of Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) manufacturing processes. He is skilled in presenting to investors and corporate partners, showcasing his ability to communicate complex scientific concepts effectively.